Since serious liver disease in childhood was first reported with genetic deficiency of axl antitrypsin (OCx ATD: protease inhibitor phenotype PiZ) by Sharp and co-workers in 1969,1 numerous reports2-5 have confirmed the association. The mode of presentation and severity of liver disease is variable.5 6 Only a proportion of al antitrypsin deficient (PiZ) children develop liver disease.3 In an epidemiological study in Sweden in which 125 PiZ infants were identified, only 11 % had hepatitis with jaundice in infancy, although 50% had biochemical evidence of liver disease.7
The alleles of ocx antitrypsin are inherited in an autosomal, codominant fashion with the PiZ state being inherited in an autosomal recessive manner. 8 Technical developments have allowed the determination of PiZ in utero9 10 but it is not possible to predict the presence or severity of liver disease. Parents faced with the option of terminating a PiZ pregnancy need information on the frequency and prognosis of liver disease in the fetus with PiZ. This prompted us to review the hepatic features observed in 136 children with PiZ, 82 of whom were prospectively studied. To determine whether liver disease followed a similar course within a particular family we have analysed the pattern of liver disease in 27 families with more than one PiZ child, together with the outcome in 20 families in the published reports.
Patients and methods
Protease inhibitor phenotyping was performed in 409 infants presenting in the first four months of life 882
Outcome of liver disease associated with a1 antitrypsin deficiency (PiZ) 883 Liver disease in infancy-presentation and outcome. In 62 of the 67 children presenting with hepatitis in. infancy, jaundice was the presenting feature, starting at varying times between the first and eleventh week of life (mean 2-5 weeks). Jaundice lasted from 2-52 weeks (mean 12-7 weeks) and was most severe in the first two months of life when the maximum serum bilirubin concentration ranged from 65-360 ,mol/l (mean 155 ,umol/l) (3*8-20 mg/dl, mean 9 1 mg/dl).
In all instances jaundice was accompanied by dark urine and by pale or acholic stools.
Life threatening haemorrhage occurred in 8 patients and was the first feature of liver disease in five. The prothrombin time was notably prolonged (>2 minutes) in all patients but was corrected within 24 hours with parenteral vitamin K. Two infants had serious cerebral haemorrhage with permanent neurological sequelae. All of the 67 patients had hepatomegaly but only 50% had splenomegaly.
The subsequent evolution of the disease has followed four patterns (Table 1 ). (Table 2 ). The last test to return to normal was the aspartate aminotransferase which became normal at ages ranging from 9 months to 11 years. (mean 4 years). Outcome of liver disease in PiZ children in other UK families and reported in families with more than one PiZ child. In Table 4 we have summarised the reported outcome of liver disease in families with more than one PiZ child. We have added data from a further 8 UK families, three identified because of liver disease and five ascertained during other family studies. In 8 families (group 1), neither sibling had clinical or biochemical evidence of liver disease.
In 6 families (group 2) both had persisting liver disease with hepatosplenomegaly, abnormal liver function tests, and increased intrahepatic fibrosis without cirrhosis. In five families (group 3) both siblings had either cirrhosis or had died at the time of reporting. Thus in 19 of these 28 families (68 %) both siblings had a similar ouctome of their liver disease. In contrast, the outcome was dissimilar in 9 families (group 4), including three with three PiZ children.
Discussion
This study confirms the frequent association of oc1 antitrypsin deficiency with serious liver disease in infancy and childhood and emphasises the variability in its severity and prognosis which makes genetic counselling so difficult, in spite of the known mode of inheritance. The high proportion (over 90 For these parents prenatal diagnosis by fetal blood sampling with termination of the pregnancy if the fetus is PiZ is an option well worth considering in spite of the 4-7% reported risk of inadvertent termination of pregnancy at fetoscopy,24 which is similar to our own unreported experience of 3 % in over 300 fetoscopies. The prenatal diagnosis of a PiM or PiMZ fetus would be a welcome alternative to termination of pregnancy, sterilisation, or permanent contraception.
Justification for fetal blood sampling is more difficult when the first affected child has only mild liver disease, but consideration has also to be given to the risks of developing incapacitating emphysema in early adult life that may occur in between 10 and 50% of PiZ individuals.22 The decision to abort a PiZ fetus cannot be made lightly. Persistent adverse psychological and social reactions were commoner in patients undergoing termination of pregnancy for genetic reasons than for social ones. 25 Skilled counselling before and support after such a termination, is essential if the procedure is not to be followed by long term morbidity. Hence, although the development of fetoscopy with the identification of PiZ phenotype early in pregnancy is an important advance, the course of the liver disease in the index case, the family response to the child's illness and Outcome of liver disease associated with o1 antitrypsin deficiency (PiZ) 887 their attitude towards subsequent children, must all be carefully considered before offering fetoscopy and possible termination of pregnancy. 
